Incidence of pruritus during and after intensive care

Incidence of pruritus during and after intensive care - ICU-ITCH

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022451

Enrollment

180

Registered

2020-08-31

Start date

2021-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Itch/pruritus L29.9 L29.8

Interventions

Group 1: 180 patients will be examined before and during intensive care and undergo a clinical subjective and objective assessment. Blood for analysis of laboratory parameters will also be drawn.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age = 18 years, written informed consent, sufficient knowledge of German, need for intensive care

Exclusion criteria

Exclusion criteria: Employees of the investigators or of the institution who are involved in the conduct of this or other clinical trials, participants who are unable to provide informed consent due to languae, psychological or somatic reasons; secondary: poor health (e.g. ventilation, sedation)

Design outcomes

Primary

Measure	Time frame
Prospective evaluation of the pruritus incidence during the first seven days of intensive care therapy: objectively through observation by the examiner, subjectively through filling out questionnaires.	—

Secondary

Measure	Time frame
Incidence of pruritus during and 1-week, 3-months, 1-year after intensive care, assessment of the severity of newly occuring pruritus, impact on quality of life.	—

Countries

Germany

Contacts

Public ContactNathalie Malewicz

Klinik für Anästhesiologie, Intensiv- und Schmerzmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Bochum

nathalie.malewicz@bergmannsheil.de0234-3020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026